Naves M, Rodríguez-García M, Díaz-López JB, Gómez-Alonso C, Cannata-Andía JB. Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporos Int. 2008; 19(8): 1161-6.
DOI: 10.1007/s00198-007-0539-1
Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP III, Herderick EE, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the pathobiological determinants of atherosclerosis in youth study. JAMA. 1999; 281:727–35.
DOI: 10.1001/jama.281.8.727
Allam AHA, Thompson RC, Eskander MA, Mandour Ali MA, Sadek A, Rowan CJ, et al. Is coronary calcium scoring too late? Total body arterial calcium burden in patients without known CAD and normal MPI. J Nucl Cardiol. 2018; 25: 1990–8.
DOI: 10.1007/s12350-017-0925-9
Bartstra JW, Mali WP, Spiering W, de Jong PA. Abdominal aortic calcification: from ancient friend to modern foe. Eur J Prev Cardiol. 2021; 28(12): 1386-91.
DOI: 10.1177/2047487320919895
Emdin M, Passino C, Michelassi C, Donato L, Pompella A, Paolicchi A. Additive prognostic value of gamma-glutamyltransferase in coronary artery disease. Int J Cardiol. 2009; 136: 80–5.
DOI: 10.1016/j.ijcard.2008.04.030
Lee DH, Jacobs Jr DR, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem. 2002; 49:1358–66.
DOI: 10.1373/49.8.1358
Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gammaglutamyltransferase and risk of NIDDM. Diabetes Care. 1998; 21:732–7.
DOI: 10.2337/diacare.21.5.732
Bozbaş H, Yıldırır A, Karaçağlar E, Demir O, Ulus T, Eroğlu S, et al. Increased serum gammaglutamyltransferase activity in patients with metabolic syndrome. Turk Kardiyol Dern Ars. 2011; 39:122–8.
DOI: 10.5543/tkda.2011.01205
Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol. 2007; 27: 2729–35.
DOI: 10.1161/ATVBAHA.107.152298
Atar AI, Yilmaz OC, Akin K, Selcoki Y, Er O, Eryonucu B. Association between gamma-glutamyltransferase and coronary artery calcification. Int J Cardiol. 2013; 167: 1264–7.
DOI: 10.1016/j.ijcard.2012.03.157
Bian LQ, Zhangb ZY, Kim SJ, Zhoue CC, Choif YH. 2012. Gamma glutamyltransferase as a novel marker of coronary artery calcification in women. J Cardiovasc Med 13:684–90.
DOI: 10.2459/JCM.0b013e328356a432
Cho HS, Lee SW, Kim ES, Mo EY, Shin JY, Moon SD, et al. Clinical significance of serum bilirubin and cgammaglutamyltransferase levels on coronary atherosclerosis assessed by multidetector computed tomography. Nutr Metab Cardiovasc Dis. 2015; 25(7): 677-85.
DOI: 10.1016/j.numecd.2015.03.014
Lee W, Ryoo JH, Suh BS, Lee J, Kim J. Association of coronary artery calcification and serum gamma-glutamyl transferase in Korean. Atherosclerosis. 2013; 226(1): 269-74.
DOI: 10.1016/j.atherosclerosis.2012.10.059
Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ. The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res. 1996; 11(7): 1010-8.
DOI: 10.1002/jbmr.5650110719
Ndrepepa G, Colleran R, Kastrati A. Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease. Clin Chim Acta. 2018; 476: 130-8.
DOI: 10.1016/j.cca.2017.11.026
Emdin M, Passino C, Michelassi C, Donato L, Pompella A, Paolicchi A. Additive prognostic value of gamma-glutamyltransferase in coronary artery disease. Int J Cardiol. 2009; 136: 80–5.
DOI: 10.1016/j.ijcard.2008.04.030
Lee DH, Jacobs Jr DR, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem. 2003; 49: 1358–366.
DOI: 10.1373/49.8.1358
Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gammaglutamyltransferase and risk of NIDDM. Diabetes Care. 1998; 21: 732–7.
DOI: 10.2337/diacare.21.5.732
Bonnet F, Ducluzeau PH, Gastaldelli A, Laville M, Anderwald CH, Konrad T, et al. Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. Diabetes. 2011; 60: 1660–7.
DOI: 10.2337/db10-1806
EmdinM, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation. 2005; 112: 2078–80.
DOI: 10.1161/CIRCULATIONAHA.105.571919
Bo S, Gambino R, Durazzo M, Guidi S, Tiozzo E, Ghione F, et al. Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress. World J Gastroenterol. 2005; 11(45): 7109-17.
DOI: 10.3748/wjg.v11.i45.7109
Anderson ME, Allison RD, Meister A. Interconversion of leukotrienes catalyzed by purified gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids. Proc Natl Acad Sci USA. 1982; 79: 1088–91.
DOI: 10.1073/pnas.79.4.1088
Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, et al. Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation. 2004; 109: 1440.
DOI: 10.1161/01.CIR.0000120558.41356.E6
Franzini M, Corti A, Martinelli B, Del Corso A, Emdin M, Parenti GF, et al. Gamma-glutamyltransferase activity in human atherosclerotic plaques–biochemical similarities with the circulating enzyme. Atherosclerosis. 2009; 202: 119-27.
DOI: 10.1016/j.atherosclerosis.2008.03.023
Bozbas H, Yildirir A, Demir O, Cakmak A, Karacaglar E, Yilmaz M, et al. Serum gamma-glutamyltransferase activity is increased in patients with calcific aortic valve stenosis. J Heart Valve Dis. 2008; 17(4): 371-5.
Cappelli S, Epistolato MC, Vianello A, Cappelli S, Mazzone A, Glauber M, et al P. Aortic valve disease and gammaglutamyltransferase: accumulation in tissue and relationships with calcific degeneration. Atherosclerosis. 2010; 213 (2): 385–91.
DOI: 10.1016/j.atherosclerosis.2010.08.063
Niida S, Kawahara M, Ishizuka Y, Ikeda Y, Kondo T, Hibi T, et al. Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor. J Biol Chem. 2004; 279: 5752–6.
DOI: 10.1074/jbc.M311905200
Hiramatsu K, Asaba Y, Takeshita S, Nimura Y, Tatsumi S, Katagiri N, et al. Overexpression of gammaglutamyltransferase in transgenic mice accelerated bone resorption and causes osteoporosis. Endocrinology. 2007; 148: 2708–15
DOI: 10.1210/en.2007-0215
O'Neill TW, Marsden D, Silman AJ. Differences in the characteristics of responders and non-responders in a prevalence survey of vertebral osteoporosis. European Vertebral Osteoporosis Study Group. Osteoporos Int. 1995; 5(5): 327-34.
DOI: 10.1007/BF01622254
Naves M, Díaz López JB, Virgós MJ, O´ Neill TW, Gómez C, Zaplana J, et al. Indices de participación y aspectos metodológicos de interés en un estudio de prevalencia de fractura vertebral en Asturias. REEMO. 1993; 2(5): 29-32.